Charles Schwab’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.66M | Buy |
|
|||||
|
2025
Q2 | $4.69M | Buy |
|
|||||
|
2025
Q1 | $3.92M | Buy |
|
|||||
|
2024
Q4 | $3.27M | Buy |
|
|||||
|
2024
Q3 | $4.71M | Buy |
|
|||||
|
2024
Q2 | $7.81M | Buy |
|
|||||
|
2024
Q1 | $6.29M | Buy |
|
|||||
|
2023
Q4 | $5.74M | Buy |
|
|||||
|
2023
Q3 | $1.77M | Buy |
|
|||||
|
2023
Q2 | $2.72M | Buy |
|
|||||
|
2023
Q1 | $1.3M | Sell |
|
|||||
|
2022
Q4 | $3.67M | Buy |
|
|||||
|
2022
Q3 | $3.54M | Buy |
|
|||||
|
2022
Q2 | $1.76M | Sell |
|
|||||
|
2022
Q1 | $2.77M | Buy |
|
|||||
|
2021
Q4 | $2.9M | Buy |
|
|||||
|
2021
Q3 | $4.46M | Sell |
|
|||||
|
2021
Q2 | $7.02M | Buy |
|
|||||
|
2021
Q1 | $6.11M | Buy |
|
|||||
|
2020
Q4 | $3.38M | Sell |
|
|||||
|
2020
Q3 | $1.77M | Buy |
|
|||||
|
2020
Q2 | $2.53M | Buy |
|
|||||
|
2020
Q1 | $484K | Buy |
|
|||||
|
2019
Q4 | $625K | Buy |
|
|||||
|
2019
Q3 | $155K | Buy |
|
|||||
|
2019
Q2 | $83K | Sell |
|
|||||
|
2019
Q1 | $216K | Buy |
|
|||||
|
2018
Q4 | $156K | Sell |
|
|||||
|
2018
Q3 | $505K | Buy |
|
|||||
|
2018
Q2 | $373K | Buy |
|
|||||
|
2018
Q1 | $459K | Buy |
|
|||||
|
2017
Q4 | $515K | Buy |
|
|||||
|
2017
Q3 | $604K | Buy |
|
|||||
|
2017
Q2 | $799K | Buy |
|
|||||
|
2017
Q1 | $185K | Sell |
|
|||||
|
2016
Q4 | $438K | Buy |
|
|||||
|
2016
Q3 | $557K | Buy |
|
|||||
|
2016
Q2 | $248K | Buy |
|
|||||
|
2016
Q1 | $164K | Buy |
|
|||||
|
2015
Q4 | $337K | Buy |
|
|||||
|
2015
Q3 | $120K | Buy |
|